ping an-杏耀平台代理注册

c&o is pleased to be appointed by shantou meiji pharmaceutical co., ltd., a subsidiary of tokyo-listed meiji seika kaisha, ltd. (“meiji seika kaisha”), as the distributor of its new-generation cephalosporin, meiact.

this five-year distribution agreement, starting from january 1, 2008, is a strong testament to the strength of c&o and demonstrates the recognition of the company by key players in the pharmaceutical industry. 

prior to the appointment of c&o as its distributor in china, the china sales force of meiji seika kaisha had already placed meiact in the market in china.